HotHouse Therapeutics | $3,835,279 | (Dec 3, 2025)
minitap | $4,100,000 | (Dec 3, 2025)
Reema Health | $19,000,000 | (Dec 3, 2025)
Certified by Founder
Lodge
Exeliom Biosciences
start up
France
- Dijon, Bourgogne-Franche-Comté
- 21/07/2023
- Series A
- $8,898,320
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
- Industry Pharmaceutical Manufacturing
- Website https://www.exeliombio.com/
- LinkedIn https://www.linkedin.com/company/nextbiotix/
Related People
Benjamin HadidaFounder
France -
Paris, Île-de-France
Biotech company builder and new therapeutic class explorer
Soxton.AI | $2,500,000 | (Dec 3, 2025)
Antares | $96,000,000 | (Dec 3, 2025)
Metri Bio | $5,000,000 | (Dec 3, 2025)
Quickture | $1,900,000 | (Dec 3, 2025)
Ripple Foods | $17,000,000 | (Dec 3, 2025)
LYRIC BIO | $6,600,000 | (Dec 3, 2025)
Ascentra | $2,000,000 | (Dec 3, 2025)
lizzyAI - AI interviews. Made human. | $5,000,000 | (Dec 3, 2025)
Trial Library | $10,000,000 | (Dec 3, 2025)